1. Market Research
  2. > Pharmaceutical Market Trends
Pharmaceutical Filtration Market: Analysis and Forecast to  2023

Pharmaceutical Filtration Market: Analysis and Forecast to 2023

  • July 2017
  • 171 pages
  • ID: 5200520
  • Format: PDF
  • By Prescient & Strategic Intelligence Private Limited

Summary

Table of Contents

According to the study, the global pharmaceutical filtration market is likely to grow significantly during the forecast period, due to increasing prevalence of chronic diseases, rising prevalence of cancer, increasing geriatric population and increasing production of biopharmaceuticals and generic drugs. In addition, rising healthcare expenditure leading to increase in research and development spending also contributes to the growth of the overall market. High cost of pharmaceutical filtration and stringent regulatory requirements for validation of filtration process are the key factors restraining the global market growth.

Insights on market segments

As per the findings of the research, the membrane filter is the largest product category in the global pharmaceutical filtration market. Membrane filter is the microporous film with specific pore size, used for retaining unwanted particles or microorganisms larger than their pore size. Microfiltration has been the largest contributor to the growth of the global market, in terms of revenue, among the various techniques for product filtration. Final product processing has been the largest application area for pharmaceutical filtration, followed by raw material filtration, cell separation, water purification and air purification. Manufacturing-scale of operation has been the largest segment of the global market, based on scale of operation.

North America stands as the largest pharmaceutical filtration market

Geographically, North America has been the largest market for pharmaceutical filtration, with the U.S. being the larger contributor to the regional market, compared to Canada. Increasing prevalence of lifestyle associated and chronic diseases, rising geriatric population and increasing production of biopharmaceuticals are the factors that have been driving the growth of the North American market for pharmaceutical filtration. The U.K. has been the largest contributor to the European market for pharmaceutical filtration, followed by Germany and France. The market is expected to witness the fastest growth in Asia-Pacific during 2017 - 2023, owing to increasing cases of chronic diseases, increasing healthcare expenditure leading to increasing research and development spending and increasing geriatric population.

Increasing prevalence of chronic diseases largely impacts the market

Globally, the increasing prevalence of chronic diseases has been playing a key role in the growth of the pharmaceutical filtration market. The rapidly increasing burden of chronic diseases further compels government organizations and healthcare providers to provide improved facilities for effective disease treatment leading to increased drug launch globally.

Prevalence of chronic diseases is increasing due to alteration in lifestyle and lack of access to preventive care. According to the Centers for Disease Control and Prevention (CDC), in 2012, approximately 117 million people in the U.S. had one or more chronic health conditions. The organization also reported that during 2013 – 2015, 54.4 million U.S. adults were diagnosed with some form of arthritis, rheumatoid arthritis, gout, lupus or fibromyalgia. Moreover, an estimated 78 million Americans aged 18 years or above will be diagnosed with arthritis by 2040.

According to the International Agency for Research on Cancer (IARC), a specialized cancer agency of World Health Organization (WHO) that promotes cancer research, 12.7 million new patients globally were detected with cancer in 2008, and the number is expected to reach 21.4 million by 2030. In addition, according to the WHO, 8.2 million deaths took place globally due to cancer in 2012, out of which 1.6 million were due to lung cancer, while 745,000 deaths resulted from liver cancer and 400,000 deaths were an outcome of esophageal cancer.

The increasing burden of chronic diseases is expected to result in higher death rates and additional economic cost. Thus, several developments have been taking place for efficient disease treatment, leading to increased production of drugs supporting the growth of the pharmaceutical filtration market globally.

Key players in the pharmaceutical filtration market

Some of the key players in the global pharmaceutical filtration market include Merck KGaA, Pall Corporation, GE Healthcare, 3M Company, Parker Hannifin Corporation, Sartorius Stedim Biotech S.A., Eaton Corporation PLC, Graver Technologies, LLC, Amazon Filters Ltd. and Meissner Filtration Products, Inc.

GLOBAL PHARMACEUTICAL FILTRATION MARKET SEGMENTATION


By Product

Membrane Filters
Mixed Cellulose Ester (MCE) Membrane Filters
Coated Cellulose Acetate (CCA) Membrane Filters
Polytetrafluoroethylene (PTFE) Membrane Filters
Nylon Membrane Filters
Polyvinylidene Difluoride (PVDF) Membrane Filters
Others
Prefilters & Depth Media Filters
Cartridge & Capsule Filters
Single-Use Systems
Filter Holders
Filtration Accessories
Others
By Technique

Microfiltration
Ultrafiltration
Nanofiltration
Others
By Application

Final Product Processing
Active Pharmaceutical Ingredient Filtration
Sterile Filtration
Protein Purification
Vaccine and Antibody Processing
Formulation and Filling Solution Filtration
Viral Clearance
Raw Material Filtration
Media and Buffer Filtration
Prefiltration
Bioburden Testing
Cell Separation
Water Purification
Air Purification
By Scale of Operations

Manufacturing-Scale
Pilot-Scale
R&D-Scale
By Geography

North America
The U.S.
Canada
Europe
The U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Rest of Asia-Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Global Autoinjectors Industry

Global Autoinjectors Industry

  • $ 4950
  • February 2020

Autoinjectors market worldwide is projected to grow by US$89.1 Billion, driven by a compounded growth of 22.7%. Rheumatoid Arthritis, one of the segments analyzed and sized in this study, displays the ...

Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2020

Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2020

  • $ 2000
  • January 2020

Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2020SummaryThe latest Pharmaceutical and Healthcare disease pipeline guide Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2020, provides an overview ...

Pneumonia Global Clinical Trials Review, H1, 2020

Pneumonia Global Clinical Trials Review, H1, 2020

  • $ 2500
  • January 2020

Pneumonia Global Clinical Trials Review, H1, 2020Summaryclinical trial report, “Pneumonia Global Clinical Trials Review, H1, 2020" provides an overview of Pneumonia Disorders Clinical trials scenario.This ...


ref:plp2017

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on